A-11 (Compugen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameA-11 (Compugen)
Drug Alias NameAng-2/Tie-2 inhibitor (Compugen)A-11 (Compugen)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiopoietin-2 inhibitorsTEK receptor tyrosine kinase antagonists
TargetsAngiopoietin-2TEK receptor tyrosine kinase
Therapy Area/IndicationsVascular eye diseaseSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompugen Ltd
Active IndicationsN/A
Inactive IndicationsVascular eye diseaseSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A